Skip to main content
TipRanks
Go Ultimate75% OFF

Northwest Biotherapeutics (NBYB) Cash flow

0 Followers

Northwest Biotherapeutics Cash Flow

DE:NBYB's free cash flow for Q3 2026 was $-8.76M. For the 2026 fiscal year, DE:NBYB's free cash flow was increased by $0.00 and operating cash flow was $-8.76M. See a summary of the company’s cash flow.

Cash Flow
Cash FlowDec 25Dec 24Dec 23Dec 22Dec 21
$ -44.76M$ -57.02M$ -53.64M$ -52.77M$ -38.30M
$ -1.81M$ -1.01M$ -3.44M$ -2.90M$ -6.01M
$ 49.33M$ 56.78M$ 52.76M$ 41.97M$ 48.13M
$ 3.04M$ 2.17M$ 2.13M$ 6.96M$ 15.17M
$ -46.27M$ -58.03M$ -57.07M$ -55.68M$ -44.31M

Currency in USD

Northwest Biotherapeutics Cash Flow

-75M-50M-25M025M50M75M201720182019202020212022202320242025OperatingInvestingFinancing